Filtros : "MORENO, FERNANDO SALVADOR" "Emirados Árabes Unidos" Removidos: "LOUREIRO, SONIA REGINA" "FFLCH" Limpar

Filtros



Refine with date range


  • Source: Current Drug Targets. Unidade: FCF

    Subjects: CARCINOGÊNESE ANIMAL, CARCINOMA HEPATOCELULAR

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      CARDOZO, M. T et al. The chemopreventive activity of β-ionone involves modulation of Rxrα, Rarβ and Coup-Tf1 expression in liver pre-neoplastic lesions in rats. Current Drug Targets, 2015Tradução . . Disponível em: https://doi.org/10.2174/1389450116666151001110507. Acesso em: 22 ago. 2024.
    • APA

      Cardozo, M. T., Furtado, kelly S., De Conti, A., Andrade, F. de O., Fernandes, L. H., Campos, A., et al. (2015). The chemopreventive activity of β-ionone involves modulation of Rxrα, Rarβ and Coup-Tf1 expression in liver pre-neoplastic lesions in rats. Current Drug Targets. doi:10.2174/1389450116666151001110507
    • NLM

      Cardozo MT, Furtado kelly S, De Conti A, Andrade F de O, Fernandes LH, Campos A, Scolastici C, Moreno FS. The chemopreventive activity of β-ionone involves modulation of Rxrα, Rarβ and Coup-Tf1 expression in liver pre-neoplastic lesions in rats [Internet]. Current Drug Targets. 2015 ;[citado 2024 ago. 22 ] Available from: https://doi.org/10.2174/1389450116666151001110507
    • Vancouver

      Cardozo MT, Furtado kelly S, De Conti A, Andrade F de O, Fernandes LH, Campos A, Scolastici C, Moreno FS. The chemopreventive activity of β-ionone involves modulation of Rxrα, Rarβ and Coup-Tf1 expression in liver pre-neoplastic lesions in rats [Internet]. Current Drug Targets. 2015 ;[citado 2024 ago. 22 ] Available from: https://doi.org/10.2174/1389450116666151001110507
  • Source: Current Drug Targets. Unidade: FCF

    Subjects: ANTINEOPLÁSICOS, ENSAIO CLÍNICO

    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      HEIDOR, Renato et al. Anticarcinogenic actions of tributyrin,a butyric acid prodrug. Current Drug Targets, v. 13, n. 14, p. 1720-1729, 2012Tradução . . Acesso em: 22 ago. 2024.
    • APA

      Heidor, R., Ortega, J. F., Conti, A. de, Ong, T. P., & Moreno, F. S. (2012). Anticarcinogenic actions of tributyrin,a butyric acid prodrug. Current Drug Targets, 13( 14), 1720-1729.
    • NLM

      Heidor R, Ortega JF, Conti A de, Ong TP, Moreno FS. Anticarcinogenic actions of tributyrin,a butyric acid prodrug. Current Drug Targets. 2012 ; 13( 14): 1720-1729.[citado 2024 ago. 22 ]
    • Vancouver

      Heidor R, Ortega JF, Conti A de, Ong TP, Moreno FS. Anticarcinogenic actions of tributyrin,a butyric acid prodrug. Current Drug Targets. 2012 ; 13( 14): 1720-1729.[citado 2024 ago. 22 ]
  • Source: Current Cancer Drug Targets. Unidade: FCF

    Subjects: DANO AO DNA, DIETA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      ONG, Thomas Prates et al. Chemoprevention of hepatocarcinogenesis with dietaty isoprenic derivatives: Cellular and molecular aspects. Current Cancer Drug Targets, v. 12, n. 9, p. 1173-1190, 2012Tradução . . Disponível em: https://doi.org/10.1117/12.925754. Acesso em: 22 ago. 2024.
    • APA

      Ong, T. P., Cardozo, M. T., Conti, A. de, & Moreno, F. S. (2012). Chemoprevention of hepatocarcinogenesis with dietaty isoprenic derivatives: Cellular and molecular aspects. Current Cancer Drug Targets, 12( 9), 1173-1190. doi:10.1117/12.925754
    • NLM

      Ong TP, Cardozo MT, Conti A de, Moreno FS. Chemoprevention of hepatocarcinogenesis with dietaty isoprenic derivatives: Cellular and molecular aspects [Internet]. Current Cancer Drug Targets. 2012 ; 12( 9): 1173-1190.[citado 2024 ago. 22 ] Available from: https://doi.org/10.1117/12.925754
    • Vancouver

      Ong TP, Cardozo MT, Conti A de, Moreno FS. Chemoprevention of hepatocarcinogenesis with dietaty isoprenic derivatives: Cellular and molecular aspects [Internet]. Current Cancer Drug Targets. 2012 ; 12( 9): 1173-1190.[citado 2024 ago. 22 ] Available from: https://doi.org/10.1117/12.925754

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024